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Spinal cord injury (SCI) is a devastating lesion to the spinal cord, which determines
the interruption of ascending/descending axonal tracts, the loss of supraspinal control
of sensory-motor functions below the injured site, and severe autonomic dysfunctions,
dramatically impacting the quality of life of the patients. After the acute inflammatory
phase, the progressive formation of the astrocytic glial scar characterizes the acute-
chronic phase: such scar represents one of the main obstacles to the axonal
regeneration that, as known, is very limited in the central nervous system (CNS).
Unfortunately, a cure for SCI is still lacking: the current clinical approaches are mainly
based on early vertebral column stabilization, anti-inflammatory drug administration,
and rehabilitation programs. However, new experimental therapeutic strategies are
under investigation, one of which is to stimulate axonal regrowth and bypass the glial
scar. One major issue in axonal regrowth consists of the different genetic programs,
which characterize axonal development and maturation. Here, we will review the main
hurdles that in adulthood limit axonal regeneration after SCI, describing the key genes,
transcription factors, and miRNAs involved in these processes (seen their reciprocal
influencing action), with particular attention to corticospinal motor neurons located in
the sensory-motor cortex and subjected to axotomy in case of SCI. We will highlight
the functional complexity of the neural regeneration programs. We will also discuss if
specific axon growth programs, that undergo a physiological downregulation during
CNS development, could be reactivated after a spinal cord trauma to sustain regrowth,
representing a new potential therapeutic approach.
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INTRODUCTION
Worldwide, every year up to 500,000 people experience a spinal cord injury (SCI), which usually
causes remarkable dysfunctions and disabilities, determining long-lasting and irreversible motor,
sensory, and/or autonomic deficits (World Health Organization, 2013). This tragic condition also
determines remarkable economic and social consequences (Thuret et al., 2006).
The pathophysiology of SCI is biphasic, consisting of a primary and a secondary phase, further
divisible in other consecutive stages (i.e., immediate, acute, intermediate, and chronic stages).
The primary phase involves the initial mechanical injury (compression, distraction, laceration, or
transection of the spinal cord): it initiates a cascade of cellular and molecular escalating events,
leading to the secondary injury phase. The first hours (immediate stage) are characterized by
massive death of neurons and glia, axonal damage, spinal cord swelling, hemorrhage, and ischemia.
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During the following days/weeks (acute and intermediate
stages), inflammation, excitotoxicity, demyelination, formation
of the cystic cavity, and glial scar occur most frequently. The
chronic phase, starting 6 months after SCI, is characterized by
maturation/stabilization of the lesion, continued scar formation,
development of cysts or syrinxes, and necrotic death (Vercelli
and Boido, 2014). In the first weeks after injury, a spontaneous
regenerative attempt can occur, even though it is not sufficient
to support a functional recovery; however, in the last phase,
the degenerative and inflammatory events become chronic
and exacerbate the damage, making any effort to repair vain
(Rowland et al., 2008).
Unfortunately, a cure for SCI is still lacking: the current
clinical approaches are mainly based on early vertebral
column stabilization, anti-inflammatory drug administration,
and rehabilitation programs. However, new experimental
therapeutic strategies are under investigation, to stimulate axonal
regrowth and bypass the glial scar. Understanding the damage
mechanisms and unraveling the intrinsic recovery potential of
CNS (although limited) is pivotal to treat SCI. In this review,
we will describe the key genes, transcription factors (TFs)
and miRNAs, involved in axonal outgrowth and regeneration,
whose activity can be intertwined and represent an intriguing
therapeutic target for SCI.
LEARNING FROM THE EMBRYONIC
DEVELOPMENT TO TRIGGER
REGENERATION IN ADULTHOOD
Motor disabilities following SCI are essentially due to axotomy
affecting corticospinal motor neurons (CSMNs), whose cell body
is located in the layer V of the motor and somatosensory cortical
areas (often referred to as sensory-motor cortex) (Figure 1). The
corticospinal tract (CST) is fundamental to regulate voluntary
movements (Oudega and Perez, 2012).
The specification of CSMNs, also known as “upper motor
neurons,” depends on genes that are progressively restricted
and specific to this cell population. CTIP2 is specifically
expressed by CSMNs, and not from other pyramidal neurons
(as callosal neurons), despite being within the same cortical
layer. Interestingly in Ctip2−/− mice CSMN axons show
defects in fasciculation, outgrowth, pathfinding, and abnormal
developmental pruning of corticospinal axons, and fail in the
connection to the spinal cord (Arlotta et al., 2005). Then, long-
distance growth of the primary axons is mediated by several
chemoattractants or repellants (including netrins, semaphorins,
the SLIT family, ephrins, and repulsive guidance molecules)
that diffuse into the local environment and guide the growing
corticospinal axons (Martin, 2005; Harel and Strittmatter,
2006). During their elongation, the axons form numerous
collateral branches; the refinement of corticospinal terminations
occurs during a protracted postnatal period and includes both
pruning of transient terminations and growth to new targets
(Martin, 2005). Moreover, during the development, neurons
can effectively extend their axons also thanks to innate genetic
programs (Seiradake et al., 2016). Among the genes involved,
Krüppel-like factor 7 (KLF7), signal transducer and activator of
transcription 3 (STAT3) and Sry-related HMG box 11 (SOX11)
encode for TFs widely expressed in the embryonic CNS and PNS
during periods of axon growth (Puttagunta et al., 2014; Tedeschi
and Bradke, 2017).
At adulthood, neurons stop expressing the genes responsible
for developmental axon elongation (He and Jin, 2016) and
epigenetic changes occur, with many of the TF binding sites that
drive axon growth-related genes becoming inaccessible (Fawcett,
2020). Indeed, one major issue in case of spinal cord trauma is
the difficulty in triggering axonal regrowth and/or reorganizing
damaged or spared descending pathways. In particular, the
CST shows very poor regeneration ability, compared to
other pathways (as the nigrostriatal, the extrapyramidal, and
autonomic pathways) that bear a relatively high capability to
regrow (Brecknell et al., 1996; Di Giovanni, 2009).
To further highlight the differences between immature and
mature CNS, in 2019 Tsujioka and Yamashita compared the gene
expression profiles of neonatal and adult sham or injured spinal
cords (pyramidotomy model), by performing RNA-sequencing
and qRT-PCR validation on C4-C7 spinal levels. In comparison
with adult mice uninjured, in the postnatal spinal cords genes
related to axonal growth, cell proliferation, and myelination were
upregulated, whereas those related to the immune response were
downregulated. After pyramidotomy, some genes responsible
for the inflammatory response were upregulated in adult mice,
suggesting that these genes might be related to the low sprouting
potential in adult mice (Tsujioka and Yamashita, 2019).
Since the developmental processes are well known, the attempt
to reactivate them within adult neurons could represent an
intriguing approach for enhancing axon regeneration after an
injury. For example, adult CST neurons are unable to induce the
Klf7 expression after axon injury, but its overexpression by AAV
injection into the murine sensory-motor cortex can trigger both
sprouting and axonal regeneration after SCI (Blackmore et al.,
2012). Similarly, Stat3 overexpression, when combined with the
activation domain from Herpes simplex virus VP6, significantly
improved the neurite outgrowth both in vitro on primary cortical
neurons and in vivo in retinal ganglion cells after optic nerve
axon injury (Mehta et al., 2016). Likewise, CST neurons fail to
spontaneously upregulate Sox11 after spinal axon injury, but its
forced viral expression at the cortical level induced sprouting and
axon regeneration: however, Sox11 overexpression also caused
a reduced dexterity in the injected animals, suggesting that it is
important to optimize not only the growth but also the function
of regenerated axons (Wang et al., 2015).
The tumor suppressor p53 (encoded by Tp53) is also a
developmentally regulated TF: when overexpressed by viral
vectors in spinal cord hemisected mice, it is able to promote CST
sprouting (Floriddia et al., 2012).
On the contrary, mature neurons can express genes that
limit axon growth in adulthood, but not in the embryo.
This mechanism is necessary to prevent ectopic axon growth
and aberrant synapse formation (Hilton and Bradke, 2017;
Tedeschi and Bradke, 2017). An example is represented by Klf4,
a transcriptional repressor of regeneration: when overexpressed
in vitro, it induces a remarkable neurite outgrowth reduction,
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FIGURE 1 | After a spinal trauma, CSMN axons can be severely damaged. CNS shows a limited capability in spontaneous regeneration after injury. Some
well-known genes responsible for axonal outgrowth during the development (underlined in the figure) can be experimentally reactivated to support regeneration in
the adulthood after SCI. Moreover, other genes and miRNAs (indicated in the panel) are emerging as interesting therapeutic targets, since able to induce sprouting
and plasticity, support neurite/axonal regrowth, induce synaptogenesis, and/or inhibit apoptosis after a trauma in the adult CNS. Created with BioRender.com.
whereas its silencing triggers axonal regeneration of retinal
ganglion cells after nerve optic nerve injury (Moore et al., 2009).
CORTICAL GENE EXPRESSION AFTER
SPINAL CORD INJURY
Many studies have investigated the genetic programs triggered
in the CSMNs after SCI during the last decades. In 2003, by
in situ hybridizations, Mason and coll. showed that the expression
of a number of growth-associated genes (including C-Jun/Ap-
1, L1cam/Ncaml1, Atf3, and Krox2-4/Egr1) was significantly
increased after intracortical axotomy (within the neocortex),
but not after an injury to the CST at the spinal level (C3/C4).
This suggested that the distance of the injury site from
the cell body can influence axotomy-induced gene expression
(Mason et al., 2003).
However, more recently, the cortical gene expression changes
after thoracic CST transaction were evaluated by microarray
analyses using total RNA isolated from rat sensory-motor
cortex layers V-VI, 1 to 60 days post-injury (DPI). Despite the
distance between the lesion site and the relative sensory-motor
cortex area, 521 genes (mainly related to wounding, apoptosis,
neurogenesis, and cytoskeletal reorganization) underwent
significant regulation, as early as 24 h after injury. The number
of modulated genes further increased in the following days,
reaching the maximum at 21 DPI. Interestingly, in presence
of a local spinal anti-scarring treatment, genes regulating the
inhibition of axon growth and impairment of cell survival were
attenuated, whereas genes associated with axon outgrowth,
cell protection, and neural development were upregulated,
compared to untreated animals. Overall, this means that
dynamic transcriptional responses are triggered in CSMNs by
SCI, and further modulated in response to distant regeneration-
promoting treatment (Kruse et al., 2011). On the contrary,
other studies have investigated the expression of factors limiting
axonal regeneration. By performing an in vitro genome-wide
loss-of-function screening on isolated injured cortical neurons,
Sekine and coll. identified many genes involved in transport,
receptor binding, and cytokine signaling pathways. Interestingly,
Rab27b was highly enriched and its lack in injured mice
(optic nerve crush) assured a remarkable axonal regeneration
(Sekine et al., 2018).
Despite the mentioned limited CNS capability in axonal
regrowth after injury, modest levels of spontaneous functional
recovery can be observed after trauma, probably due to the
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plasticity of intact circuitry. By performing a comparison between
the transcriptomic profiles of adult murine intact “sprouting”
CSMNs in active growth mode with intact “quiescent” CSMNs
after pyramidotomy, Fink et al. (2017) identified some pro-axonal
growth pathways able to drive functional plasticity within intact
spinal circuits after partial SCI: in particular, lipid phosphate
phosphatase-related protein type 1 (PLPPR1) and LPAR1 act
as intrinsic axonal growth modulators for intact CSMNs after
adjacent injury (Fink et al., 2017).
Unlike the CNS, PNS maintains a high regenerative ability
during the entire individual lifespan, since after peripheral
neuron axotomy hundreds of regeneration-associated genes
(RAGs) can be activated (van Kesteren et al., 2011). A typical
RAG response involves several hundred genes, including TFs
(as Stat3, Sox11, c-Jun, already mentioned) or effector RAGs (as
Gap43, Cap23, Scg10, Npy), that can successfully support axonal
regrowth (Tedeschi, 2012; Ma and Willis, 2015). Instead, in
central neurons, a very limited or no RAG-response is observed.
However, by acting on the signaling pathways active in the
PNS, it is possible to induce GAP43 expression and sustain
axonal regrowth also at the central level. For example, IL-6
treatment after SCI was shown to activate the Jak/Stat3 and
PI3K/Akt pathways, and in turn upregulate GAP43, promoting
neurite outgrowth in vitro and synaptogenesis in vivo. Similarly,
the administration of TDZD-8 (a GSK-3 inhibitor) after SCI
is able to increase the GAP43 expression, increase the density
of cortical spinal tract fibers at the injury site, and improve
the motor performance of SCI rats (Lei et al., 2019). On
the other hand, by inhibiting the RhoA kinase activation, the
administration of the natural compound β-Elemene can enhance
GAP43 expression and neurite outgrowth in SCI rats (Wang
et al., 2018). Overall, this means that many molecular cascades
converge on GAP43, which clearly represents a crucial target for
axonal regeneration in the CNS too.
MiRNAs
MiRNAs are small non-coding RNAs, which negatively regulate
gene expression at post-transcriptional level. In case of SCI, they
can cooperate in influencing the molecular pathways regulating
axon regeneration as well as inflammation, apoptosis, and
remyelination (Ghibaudi et al., 2017). The activation/regulation
of miRNAs can also occur at the level of the sensory-motor cortex
where the cell bodies of CSMNs are located.
During the last years, both in vitro and in vivo studies
have been performed to unravel the role of the miRNA
network in this scenario. For example, miR-20a and miR-
128 were able to induce the axon outgrowth of the cultured
cortical neurons by regulating the PSD-95/Dlg/ZO-1 homology-
Rho guanine nucleotide exchange factor (PDZ-RhoGEF)/Ras
homolog gene family member A (RhoA)/GAP43 axis (Sun et al.,
2013). Moreover, miR-20a plays a role in SCI-induced neuronal
apoptosis through repression on the anti-apoptotic Mcl-1, as
demonstrated both in vitro (in Neuro-2A neuroblastoma cell
line) and in vivo (contusive SCI model) (Liu et al., 2015). It can
also regulate Stat3 (see above), although until now this function
has been only demonstrated during early embryonic branching
morphogenesis in the lung (Carraro et al., 2009). Interestingly,
these studies highlight the multiple functional roles of miR-20,
also in case of SCI.
The Stat3/Gap43 pathway is targeted also by miR-17-5p:
indeed the in vitro downregulation of miR-17-5p is able
to promote the axon regeneration of the cortical neurons,
suggesting that this miRNA may represent another interesting
target for SCI (Zhang et al., 2020).
At the cortical level, miRNAs can also regulate other functions
in SCI, apparently not directly correlated with axonal regrowth,
such as neuroprotection. For example, after a spinal cord
transection at C6 level in mice, miR-7b-3p is significantly
upregulated in the sensory-motor cortex. Moreover, in vitro
and in vivo experiments demonstrated that this miRNA can
exert a dual role, in the attempt to maintain the axotomized
CSMNs more plastic on one side, and to protect them
from apoptotic death on the other. Indeed the hypothesis is
that increasing the expression of miR-7b-3p after SCI could
stimulate the reactivation of developmental programs silenced
in adult upper MNs, meanwhile supporting their survival
(Ghibaudi et al., 2021).
REGENERATION IN INVERTEBRATES
AND LOWER VERTEBRATES
Unlike mammals, axonal regeneration spontaneously occurs in
some invertebrates (as the nematode Caenorhabditis elegans, the
crustacean Parhyale hawaiensis, and the cephalopod Octopus
vulgaris) and lower vertebrates (including the axolotl Ambystoma
mexicanum and the lamprey Petromyzon marinus), assuring
a substantial recovery of locomotor function after SCI. This
successful response is due to the activation of mechanisms
for axonal elongation and selection of appropriate postsynaptic
targets, together with limited necrosis at the injury site, and
a permissive environment at the spinal cord level (McClellan,
1998; Agata and Inoue, 2012). The absence of glial scar and
astrocyte activation can be relevant to support the regeneration
of descending axons, as demonstrated in salamanders (Ryczko
et al., 2020). Interestingly, the descending pathways mainly
originate from cephalic ganglia, diencephalon, mesencephalon,
or rhombencephalon (depending on the species): this can further
justify why, unlike the tracts originating from the cerebral cortex,
the subcortical descending tracts evolutionarily bear a relatively
higher capability to regrow in humans.
Moreover, although a combination of factors seems necessary
to facilitate fiber regeneration in some lower vertebrates and
invertebrates, it is evident that the neuronal genetic programs
are fundamental in these species as well. However, it remains
unclear why turning off the developmental processes responsible
for regeneration and plasticity has represented an evolutionary
step forward for the higher vertebrates. Some theories justify this
apparent contradiction with the high energy demanding process
for a complex hard-wired nervous system (Fawcett, 2020).
Moreover, studying the regenerative capabilities of invertebrates,
in the attempt to identify orthologs RAGs, could represent an
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intriguing approach for stimulating silenced evolutionary neural
regeneration pathways in adult mammalian injured CNS.
CONCLUSION
In the last years, remarkable progress has been made to
understand the mechanisms involved in the CSMN axonal
degeneration and “tentative” regeneration after SCI. However,
deciphering the genetic differences between development and
adult (re)generation remains elusive: some well-known genes
(as KLF7, SOX11, STAT3) are active during development and
represent potential therapeutic targets in adulthood, whereas
in the adult CNS additional genes/TFs/miRNAs can be
involved (Figure 1).
It should be also mentioned that, although recapitulating some
developmental aspects and involving similar genes/pathways (as
STAT3), these two processes differ, in part conditioned by other
extrinsic aspects. In case of SCI, the environment is hostile
and several inhibitory mechanisms can contribute to limit the
intrinsic regenerative attempt of CSMN axons. Among the most
known inhibitors deeply studied in the last years, we can mention
NogoA, chondroitin sulfate proteoglycans, myelin-associated
glycoprotein, oligodendrocyte myelin glycoprotein, semaphorin
3A, and tenascin-C (Fawcett, 2020). Therefore, the activation
of TFs and miRNAs (as enhancers to drive the regeneration
program) could be not enough after a CNS injury. To induce
and sustain a substantial axonal regrowth, combined therapeutic
approaches are probably needed, both by limiting the potential
inhibitory mechanisms and activating transcriptional programs
in the axotomized neurons.
With modern experimental approaches, discriminating the
different “players” involved in regeneration should be easier.
Although many challenges remain, the current technological
advances will allow providing new insights into how axonal
regrowth is promoted, possibly even exploiting the silenced
developmental processes. For example, the combination of multi-
layer omics (epigenomics, transcriptomics, proteomics. . .) and
computational methods will help to study axon regeneration
mechanisms and rebuild injured neural circuitries (Tedeschi
and Popovich, 2019). Moreover, genetic reprogramming (to
rejuvenate mature neurons) can represent another interesting
strategy [e.g., the forced viral expression of SOX11 promoted CST
sprouting and regrowth in both acute and chronic injury models
(Wang et al., 2015)]. Other modern approaches (including
circuit-specific genetic technologies, DREADDs, bioengineered
rabies) can assess the succeeded axonal regrowth and functional
connectivity after SCI (Hilton and Bradke, 2017).
Moreover, in addition to corticospinal projections, other
descending pathways should be considered for regeneration, such
as extrapyramidal and autonomic pathways. For instance, the
raphespinal and the rubrospinal seem to be more plastic in
the adult than the CST. In fact, growth-related genes (c-JUN,
Galectin-1, beta-II-Tubulin) are upregulated in raphe and red
nuclei, but not in upper motor neurons (Di Giovanni, 2009).
Their regrowth, even though not sufficient to elicit voluntary
movements, could support automatic circuits in the spinal cord
and improve movements. Moreover, also ascending pathways
should be recovered to provide a sensory feedback to supraspinal
and spinal motor circuits.
As an additional consideration, we believe that, to truly
overcome CNS injury, we still need to increase our knowledge.
Indeed, until now, in the SCI field, the researchers have mainly
investigated the expression of genes and non-coding RNAs at
the injury site, often disregarding the cerebral cortex where
CSMNs reside. Of course, these studies have been pivotal to
unravel pathogenetic events occurring after an injury (related to
local cell death, inflammation, oxidative stress, demyelination,
and the inhibitory mechanisms): nevertheless, it is mandatory to
further investigate the transcriptional and structural remodeling
occurring within the sensory-motor cortex, without neglecting
the significant impact of CSMN axotomy on the whole
regenerative process.
In conclusion, the review aimed to highlight the complexity of
the genetic system orchestrating the central axon (re)generation:
we are probably looking only at the tip of the iceberg, just
starting now to identify some of the main key players involved.
Interestingly the Gap43 expression can be modulated by the TF
Stat3, which in turn can be targeted by some miRNAs (e.g., miR-
20a and miR-17-5p): this is an interesting converging pathway,
currently representing one of the most promising potential
therapeutic targets in the SCI field, since different molecules able
to modulate its activity are already available.
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